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Abstract
Background: Haemostatic impairment can have a crucial impact on the outcome of emergency patients, especially
in cases of concomitant antithrombotic drug treatment. In this prospective observational study we used a point of
care (POC) coagulometer in a prehospital physician-based emergency medical system in order to test its validity
and potential value in the treatment of emergency patients.
Methods: During a study period of 12 months, patients could be included if venous access was mandatory for
further treatment. The POC device CoaguChek® was used to assess international normalized ratio (INR) after
ambulance arrival at the scene. Results were compared with in-hospital central laboratory assessment of INR. The
gain of time was analysed as well as the potential value of POC testing through a questionnaire completed by the
responsible prehospital emergency physician.
Results: A total of 103 patients were included in this study. POC INR results were highly correlated with results of
conventional assessment of INR (Bland-Altman-bias: 0.014). Using a cutoff value of INR >1.3, the device’s sensitivity
to detect coagulopathy was 100 % with a specificity of 98.7 %. The median gain of time was 69 min. Treating
emergency physicians considered the value of prehospital POC INR testing ‘high’ in 9 % and ‘medium’ in 21 % of all
patients. In patients with tracer diagnosis ‘neurology’, the value of prehospital INR assessment was considered ‘high’
or ‘medium’ (63 %) significantly more often than in patients with non-neurological tracer diagnoses (24 %).
Conclusions: Assessment of INR through a POC coagulometer is feasible in prehospital emergency care and
provides valuable information on haemostatic parameters in patients. Questionnaire results suggest that POC INR
testing may present a valuable technique in selected patients. Whether this information translates into an improved
management of respective patients has to be evaluated in further studies.
Introduction
Impaired haemostasis can have a crucial impact on the out-
come of emergency patients. Trauma-associated bleeding is
considered a major risk factor for increased mortality and
even small blood clots can have devastating effects if they
are localized within the central nervous system. Further-
more, antithrombotic agents are increasingly prescribed as
the population ages and anticoagulant-associated coagulop-
athy may have detrimental effects in patients with acute
haemorrhage [1].
Point of care (POC) devices have been developed for pa-
tient self-monitoring of anticoagulation therapy with vita-
min K antagonists (VKA). Assessment of prothrombin
time international normalised ratio (INR) is achieved
within one minute through analysis of a drop of blood
and results have been highly correlated with results of
conventional assessment of INR [2, 3]. Several reports
have demonstrated the value of an in-hospital use of POC
devices for rapid assessment of INR. In emergency set-
tings, their use has reduced the ‘door to needle’ time for
thrombolysis in acute ischemic stroke [4] or urgent
neurosurgical intervention in anticoagulated patients
[5]. Theoretically, prehospital assessment of INR may
further optimize the emergency management of re-
spective patients and may also facilitate prehospital ad-
ministration of pro-haemostatic substances.
The primary aim of this prospective observational
study was to test the potential value of prehospital INR
assessment through emergency medical service (EMS).
For this purpose we used a POC device in a physician-
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based EMS ambulance and analysed the gain of time
and accuracy of obtained results compared with conven-
tional central laboratory (CL) assessment of INR. For
each patient included in this study, the EMS physician
completed a questionnaire regarding the potential value
of INR assessment in the specific case.
Methods
Study design and data collection
The study was approved by the local Ethics Committee
(S-085/2013). All patients (>18 years) treated by a
physician-based prehospital EMS were eligible for inclu-
sion if a venopuncture was performed during treatment in
order to establish intravenous access. Patients could be in-
cluded if a physician briefed in the use of the device was
present and logistical circumstances allowed study inclu-
sion. Written consent to study participation was obtained
either prior to study participation or retrospectively after
recovery of consciousness. After insertion of an intraven-
ous line (Braunüle®, BBraun, Melsungen, Germany), a
drop of blood was collected from the needle and was ap-
plied on the test strip of the POC device for assessment of
INR. The point of time and result of INR assessment were
documented. The results were not used to guide further
patient treatment. After patient admission to the hospital,
the EMS emergency physician completed a questionnaire
regarding the potential value of prehospital INR assess-
ment in the treatment of the specific patient. INR values
of laboratory examination and time points of availability
were provided by respective hospitals. The cutoff value for
‘coagulopathic’ was defined at INR > 1.3.
Point of care device for assessment of prothrombin time
The POC device CoaguChek XS® (Roche Diagnostics,
Mannheim, Germany) was used in this study. It is a
small (128×78×28 mm), battery-operated and portable
device which can be easily used through a screen-based
operating system. It uses the amperometric detection of
thrombin in a 10 μL sample of whole blood with a dis-
posable test strip and measures INR from 0.8 to 8.0. INR
values outside this range may produce test errors indi-
cated by ‘error’. Blood has to be applied on the test strip
within 2 min after venopuncture. Thereafter, initiated
coagulation processes may produce errors. Environmen-
tal temperature has to be within 5 °C to 35 °C because
of enzymatic reactions incorporated on the test strip
during assessment of INR. In those cases, ‘error’ is dis-
played and INR assessment is not initiated.
Questionnaire
The questionnaire included three questions regarding
the potential value of INR assessment in the specific
case and was completed by the EMS physician directly
after hospital admission of the patient: Question 1: ‘How
do you rate the overall value of prehospital assessment
of INR in the treatment of this patient (1: no, 2: low, 3:
medium, 4: high)’? Question 2: ‘Would you have sus-
pected coagulopathy in this patient after obtaining med-
ical history and clinical examination (yes/no)’? Question
3: ‘Would you have considered prehospital administra-
tion of prothrombin complex concentrate in this patient
(yes/no)’?
Statistical analysis
Descriptive statistical analyses were used for numerical
values. POC INR and CL INR values were compared with
the Spearman’s rank correlation test. To test the agree-
ment between both methods, we carried out a Bland-
Altman analysis9. For comparison of questionnaire results
(Question 1), the Fisher exact test was carried out between
results of patients with a neurological tracer diagnosis and
patients with non-neurological tracer diagnoses results
(‘high’/’medium’ value vs. ‘low’/’no’ value). A p-value <0.05
was considered statistically significant. All data were ana-
lysed with the statistical software GraphPad Prism 5
(GraphPad Software, La Jolla, USA).
Results
A total of 103 patients (male: 53, female: 50) were included
in this study. Patient characteristics are summarized in
Table 1. Tracer diagnosis categories for ambulance calls
were cardiovascular (n = 39), trauma (n = 19), neurology
(n = 16), respiratory (n = 9) and other (n = 20).
Technical difficulties occurred when temperature
levels were lower than 5 °C or above 35 °C. In these
cases, an error message was displayed. ‘Error message 5’
was displayed in cases of insufficient blood amount indi-
cating errors in applying blood. The median INR ob-
tained through POC coagulometry in patients was 1.10
[IQR: 1.0-1.2]. CL INR assessment upon hospital arrival
was carried out in 89 patients (median INR: 1.03 [IQR:
0.98-1.13]). The correlation between POC INR and CL
INR was 0.68 (p < 0.0001, Fig. 1). Bland Altman analysis
revealed a bias of 0.014 with 95 % limits of agreement
between −0.30 and +0.33 (Fig. 2). The variability of POC
INR increased with higher INR results. POC INR result
was 1.4 in one patient while CL INR was 1.26 and there-
fore, this patient was falsely classified as ‘coagulopathic’
by POC coagulometry. All patients with CL INR > 1.3
were correctly identified as ‘coagulopathic’ by POC coa-
gulometry. POC testing had a sensitivity of 100 % and a
specificity of 98.7 % for detecting coagulopathy (Table 2).
All patients with coagulopathy had been treated with
VKA. The median time gained through POC testing
compared with CL assessment of INR was 69 min, ran-
ging from 33 to 336 min).
Questionnaire results demonstrated that POC INR re-
sults were considered of ‘high’ or ‘medium’ value in the
Beynon et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine  (2015) 23:58 Page 2 of 6
treatment of 31 patients (30 %) (Table 3). In patients
with neurological tracer diagnoses, POC INR results
were considered significantly more often ‘high’ or
‘medium’ than in patients with a non-neurological tracer
diagnosis (63 % vs. 24 %) (p < 0.05). Prehospital adminis-
tration of prothrombin complex concentrate (PCC)
would have been considered in a 78-year-old male pa-
tient with active upper gastrointestinal bleeding. In this
patient, POC testing revealed an INR of 3.0 and CL INR
result was 2.89 after admission to the hospital.
Discussion
In prehospital emergency care, impaired haemostasis can
have a major impact on patient outcomes. Guidelines for
the management of bleeding in major trauma patients rec-
ommend ‘monitoring and measures to support coagula-
tion initiated as soon as possible’ [6]. Other scenarios that
involve management of haemorrhage and commonly
occur in prehospital emergency care include bleeding
from the upper gastrointestinal or nose and throat tract.
Results of several studies have suggested beneficial effects
of an in-hospital use of POC devices for assessment of co-
agulation. The emergency management of anticoagulated
patients is significantly hastened in cases of ischaemic
stroke [4], intracerebral haemorrhage [7] and conditions
requiring urgent neurosurgical intervention [5]. In those
studies, test results were highly correlated with results
of conventional INR assessment, confirming previous
Table 1 Patient characteristics and results of point-of-care (POC) testing as well as agreement with central laboratory assessment of
international normalized ratio (INR) and time gained through the use of the device
Tracer
diagnosis
Age Age POC INR POC INR CL INR CL INR Bland-Altman Time gain Time gain
Median Range Median (IQR) Range Median (IQR) Range bias Median (IQR) Range
Cardiovascular 77 35 – 88 1.10 (1.0 – 1.2) 0.8 – 3.3 1.04 (0.97 – 1.13) 0.94 – 3.13 0.019 67 (56 – 85) 41 – 318
(n = 39)
Trauma 62 29 – 93 1.00 (1.0 – 1.2) 0.9 – 2.2 1.00 (0.98 – 1.10) 0.90 – 1.84 0.053 63 (39 – 161) 33 – 336
(n = 19)
Neurology 64 18 – 89 1.10 (1.0 – 1.5) 0.9 – 3.9 1.07 (0.99 – 1.34) 0.88 – 4.94 0.092 67 (51 – 78) 41 – 143
(n = 16)
Respiratory 72 28 – 89 1.10 (1.1 – 1.5) 1.0 – 2.7 1.00 (0.95 – 1.03) 0.93 – 1.04 0.100 78 (53 – 155) 37 – 263
(n = 9)
Other 59 20 – 81 1.00 (1.0 – 1.1) 0.9 – 3.0 1.00 (0.96 – 1.05) 0.91 – 2.89 0.038 75 (57 – 98) 34 – 211
(n = 20)
All 69 18–93 1.10 (1.0 – 1.2) 0.8 – 3.9 1.03 (0.98 – 1.13) 0.88 – 4.94 0.014 69 (54 – 99) 33 – 336
(n = 103)
Fig. 1 Scatter graph of Spearman’s correlation. The r value of international normalized ratio (INR) results of both test methods was 0.68
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findings of studies on the validity of test results in the
outpatient setting [2, 3].
Only very few reports on the assessment of haemostatic
parameters in prehospital emergency care currently exist.
We have previously reported a case of preshospital identi-
fication of excessive anticoagulation through POC coagu-
lometry in a patient with active bleeding [8]. Lendrum et
al. reported the case of CoaguChek®-guided INR assess-
ment by a helicopter-based EMS in an anticoagulated
head-injured patient who received prothrombin com-
plex concentrate prior to hospital admission in order to
normalize haemostasis [9]. A further study on the pre-
hospital thrombolysis of patients with ischaemic stroke
in a CT scanner-equipped ambulance also included
POC assessment of INR [10].
The findings of our study demonstrate that prehospital
assessment of INR is feasible with the use of a POC coa-
gulometer. Technical difficulties mainly occurred when
manufacturer’s instructions were not followed. In cases of
outdoor temperature of below 5 °C or higher than 35 °C,
INR assessment was not possible as well as when blood
was applied later than two minutes after venopuncture.
An error message was displayed in those cases and INR
assessment was not initiated. Importantly, if INR assess-
ment was initiated by the device and results were ob-
tained, they were highly correlated with conventional
laboratory assessment of INR. However, limited numbers
of patients with high INR were included in the sample
and Bland-Altman analysis suggested greater variability in
correlation at high INR. The mean INR deviation was
0.014 with 95 % agreement of −0.30 to +0.33 and those re-
sults are considered acceptable in clinical practice. The
majority of patients had no signs of coagulopathy with
normal INR measured by POC and CL, but all patients
with coagulopathy (INR >1.3) had been identified by pre-
hospital coagulometry.
Our findings also demonstrate that POC coagulometry
is associated with a major gain of time regarding the as-
sessment of haemostasis in emergency patients. In this
study, the median time gained through the use of the
POC INR device was 69 min and this gained time can
provide substantial benefits in cases of emergency sce-
narios such as intracranial haemorrhage. Early assess-
ment of INR in selected patients may also aid in transfer
Fig. 2 The Bland-Altman-Plot demonstrates the agreement between point-of-care (POC) and central laboratory (CL) assessment of international
normalized ratio (INR). The mean bias was 0.014 (continuous line) with 95 % limits of agreement of −0.30 to +0.33 (dotted lines)
Table 2 Point-of-care (POC) testing international normalized ratio (INR) had a specificity of 100 % and a sensitivity of 98.7 % in
detecting coagulopathy, defined as INR >1.3 through central laboratory (CL) assessment
CL coagulopathic CL non-coagulopathic Total
(INR >1.3) (INR ≤1.3)
POC coagulopathic 10 1 11
(INR >1.3)
POC non-coagulopathic 0 78 78
(INR ≤1.3)
Total 10 79
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decisions as accuracy of prehospital triage positively affects
survival and resource utilization [11]. This especially ap-
plies to rural areas with limited availability of Level I emer-
gency centres. Prehospital assessment of INR may also
hasten the further patient management with regard to
haemostatic measures after hospital admission. Further-
more, the prehospital administration of PCC based on
POC coagulometry findings could have distinct advantages.
PCC formulas do not have to be thawed and enable a rapid
reversal of anticoagulation. In our patient collective, pre-
hospital administration of PCC would have been consid-
ered by the EMS physician in one patient who suffered
from active upper GI bleeding and an INR of 3.0 as re-
vealed by POC coagulometry. The CRASH-2 trial indi-
cated that prehospital administration of the antifibrinolytic
drug tranexamic acid reduces mortality in bleeding trauma
victims [12] and those findings underscore the potential of
haemostatic therapy in prehospital emergency care. POC
devices for assessment of haemostasis may play a key role
in optimising prehospital coagulation therapy [13].
There are several limitations of our study. Although pa-
tients were enrolled prospectively, they were not recruited
consecutively. Statistical analyses regarding the validity of
test results were carried out, but no patient had significant
coagulopathy of an origin other than VKA-associated (eg,
traumatic coagulopathy). Therefore, it is not possible to
draw conclusions on the system’s capability of detecting
other coagulopathies. Assessment of INR reflects only a
proportion of the complex pathophysiological cascades of
haemostasis. Although INR is suitable to assess the degree
of anticoagulation in patients treated with VKA, it is not
able to reflect various other sources of coagulopathy.
Available studies on the identification of traumatic co-
agulopathy by POC coagulation testing have reported
conflicting results regarding this issue. Cotte et al.
have reported the use of CoaguChek® in a military set-
ting and included 40 patients with war trauma [14]. In
total, 69 measurements were compared with labora-
tory assessment of prothrombin time. The Bland-
Altman showed a difference of 5.8 % (95 % confidence inter-
val −14.9 % to +26.6 %). A prospective study by Mitra and
colleagues included 72 trauma patients of whom 38 were
considered coagulopathic (INR > 1.5) [15]. Results of the
CoaguChek XS® were obtained upon hospital arrival of pa-
tients and compared with standard laboratory assessment of
INR. The Bland-Altman plot demonstrated a mean differ-
ence of −0.1 with limits of agreement at −1.6 and +1.3. The
POC INR had a specificity of 86.1 % and a sensitivity of
63.9 %. The authors concluded that POC INR measure-
ments during trauma reception cannot be used to identify
patients with traumatic coagulopathy. Several factors such
as hemodilution and disseminated intravascular coagulation
have been discussed as reasons for discrepancy to the results
of studies on the accuracy of POC INR testing in anticoagu-
lated patients. As recently reviewed by Schött, viscoelastic
and platelet function monitoring may also represent suitable
techniques for prehospital POC coagulation testing [16]. A
further limitation of our study is that CL INR assessment
after hospital arrival of the patient was carried out with a
significant delay compared with POC INR testing. As
haemostasis is a dynamic process, haemostatic parameters
could change even within short periods of time and this es-
pecially applies to trauma patients with active bleeding.
Despite these limitations, we present the first study on
prehospital POC coagulometry in emergency patients
and our findings support the potential of POC coagula-
tion testing to optimise treatment modalities of selected
patients. The questionnaire results demonstrate that the
value of prehospital INR assessment was considered
highest in patients with the tracer diagnosis category
‘neurology’. As patients with anticoagulant therapy are
particularly prone to ischemic and hemorrhagic strokes,
this supports the hypothesis that prehospital INR assess-
ment may enhance the prehospital emergency care of se-
lected patients treated with oral anticoagulants. While
current techniques allow assessment of anticoagulation
degree, further research is needed to define its value in
the treatment of patients with coagulopathy of other
Table 3 Questionnaire results regarding the value of prehospital assessment of international normalized ratio (INR)
Tracer diagnosis Questionnaire (1) Questionnaire (2) Questionnaire (3)
Value of INR assessment in treatment of patient Disagreement of
clinical vs. POC
assessment of
coagulopathy
Consideration of
prehospital
administration of
prothrombin
complex
concentrate
No Low Medium High
Cardiovascular (n=39) 16 (41 %) 16 (41 %) 5 (13 %) 2 (5 %) 1 (3 %) 0
Trauma (n=19) 4 (21 %) 8 (42 %) 5 (26 %) 2 (11 %) 1 (6 %) 0
Neurology (n=16) 3 (19 %) 3 (19 %) 7 (44 %) 3 (19 %) 3 (19 %) 0
Respiratory (n=9) 3 (33 %) 3 (33 %) 2 (22 %) 1 (11 %) 2 (22 %) 0
Other (n=20) 13 (65 %) 3 (15 %) 3 (15 %) 1 (5 %) 0 (0 %) 1
All (n=103) 39 (38 %) 33 (32 %) 22 (21 %) 9 (9 %) 7 (7 %) 1
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origin. Prehospital administration of PCC based on coagu-
lometry findings may improve outcome of anticoagulated
patients with severe haemorrhage or intracranial bleeding
but this hypothesis has to be proven in future research.
Conclusion
Prehospital coagulometry by EMS is feasible and enables
rapid INR assessment prior to hospital admission of pa-
tients. The considerable time gained may have beneficial
effects on the treatment of emergency patients. Although
INR test results have been validated for assessment of
anticoagulation in VKA-treated patients, the accuracy in
patients with coagulopathy of other origin is unclear. Fur-
ther research is needed to characterise the potential and
limitations of POC coagulation testing devices in prehos-
pital emergency care.
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